LISA WILEY: Open Payments
NPI 1346005337 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 44 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $474 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 20 | $161 |
| Calliditas Therapeutics US Inc. | 4 | $110 |
| Novartis Pharmaceuticals Corporation | 2 | $65 |
| Amgen Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| SCPHARMACEUTICALS INC. | 2 | $35 |
| AKEBIA THERAPEUTICS INC | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Mozarc Medical US LLC | 1 | $24 |
Products named: TARPEYO, Fabhalta, JARDIANCE, TAVNEOS, BENLYSTA, FUROSCIX, Vafseo, JYNARQUE.
Industry payments across MO — which companies pay providers there.
